Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > For professionals > Policymakers
At JDRF, we are dedicated to making a positive impact on the lives of everyone living with type 1 diabetes by actively participating in advocacy work.
Our goal is to shape healthcare consultations regarding access to new treatments and technology. You can learn more about our efforts in influencing policies that affect people with type 1 by exploring our comprehensive policy papers.
A crucial aspect of our work involves actively engaging and responding to consultations from public bodies such as the National Health Service (NHS), the National Institute for Health and Care Excellence (NICE), and the UK and Devolved Governments.
We contribute real-life case studies, gather insights from academic experts and healthcare professionals, ensuring that the unique needs and challenges of people with type 1 diabetes are taken into account when making healthcare decisions and developing guidelines.
We regularly publish our policy positions on key issues related to type 1 diabetes. These positions are based on expert research, input from the type 1 community, and the valuable insights provided by individuals and professionals in the field. By making our positions publicly available, we aim to raise awareness and advocate for necessary changes that will enhance the lives of everyone living with type 1 diabetes.
We actively engage in efforts to influence government policies through briefings and meetings with Parliamentarians. By working closely with policymakers, we strive to ensure that the concerns and voices of the type 1 diabetes community are heard and addressed.
Through strategic advocacy, we aim to drive policy changes that enhance access to innovative treatments, support research funding, and improve overall healthcare for all individuals with type 1 diabetes.
Read how JDRF gives information and evidence to policymakers and healthcare bodies to inform policies, debates, and laws relating to type 1 diabetes.
View and download our reports and resources that can help you to make type 1 diabetes a priority for policymakers and healthcare professionals.
Read JDRF’s position on a range of issues including our position regarding animal research, telemedicine, access to type 1 technology, and ‘DIY’ technologies.
Our international research programme means that life-changing treatments and developments for type 1 diabetes are in clinical trials around the world.
We commissioned social research to understand the varying pandemic experiences of different people affected by type 1 diabetes in the UK. The experiences shared for the report depict an enormous withdrawal of NHS services during the pandemic, leading to starkly unequal access to type 1 diabetes care.
We’ve written a letter to Gillian Keegan MP, Secretary of State for Education, asking her to make exemptions to the Government’s policy on banning mobile phones in schools. We thought you might like to read it.
As part of its assessment of hybrid closed loop (HCL), the National Institute for Health and Care Excellence (NICE) has today published an additional consultation on its roll out.
Insulet, the company who make Omnipod® products, has announced that their Omnipod® 5 hybrid closed loop (HCL) technology is now available in the UK.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
